期刊文献+

急性心肌梗死溶栓治疗的临床研究 被引量:8

下载PDF
导出
摘要 目的:观察静脉溶栓治疗急性心肌梗死(AM I)患者的临床疗效。方法:AM I90例分为经静脉溶栓治疗65例为溶栓组,同期未溶栓治疗25例为未溶栓组,对比分析两组临床效果。结果:溶栓组临床血管再通率为81.5%,溶栓组再通者病死率为3.8%,发生心室重构(LVRM)18.8%,左室射血分数(LVEF)均值61.4±5.8,发生严重心律失常16.9%。溶栓未通和未溶栓者病死率为35.1%,LVRM 72.9%,LVEF 27.3±3.2,严重心律失常32.4%。结论:静脉溶栓治疗急性心肌梗死可降低病死率,减少心室重构及恶性心律失常的发生,改善心功能。
出处 《华夏医学》 2005年第6期951-952,共2页 Acta Medicinae Sinica
  • 相关文献

参考文献5

二级参考文献14

  • 1Van de Weft F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST - segment elevation.Eur Heart J,2003;24:28 - 66. 被引量:1
  • 2Eagle KA,Goodman SG,Avezum A, et al. Practice variation and missed opportunities for reperfusion in ST - segment - elevation myocardial infarction: Finding from the Global Registry of Acute Coronary Events (GRACE). Lancet, 2002; 359: 373 - 377. 被引量:1
  • 3The Assessment of the Safety and Efficacy of a new thrombolytic Regimen(ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heperin: the ASSENT-3 randomised trial in acute myocardial infarction.Lancet, 2001;358:605 - 613. 被引量:1
  • 4Wallentin L, The ASSENT - 3 PLUS trial. Presented at the 75th scientific sessions of the American Heart Association in Chicago, November 2002. 被引量:1
  • 5Montalescot G,Barragan P,Wittenberg O,et al. Platelet glycoprotein Ⅱ b/Ⅲ a inhibition with coronary stenting for acute myocardial infarction.N Engl J Med,2001;344:1895 - 1903. 被引量:1
  • 6Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med,2002;346:957 - 966. 被引量:1
  • 7Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST- segment elevation. N Engl J Med,2001;345:494- 502. 被引量:1
  • 8Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long - term therapy in patients undergoing percutaneous coronary intervention: the PCI - CURE study.Lancet, 2001 ; 358: 527 - 533. 被引量:1
  • 9Simoons ML. Effects of glycoprotein Ⅱ b/Ⅲ a receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV - ACS randomized trial.Lancet,2001;357:1915 - 1924. 被引量:1
  • 10Goodman SG, Cohen M, bigomi F, et al. Randomised trial of low molecular weight heparin (enoxaparin) Versus unfractionated heparin for unstable coronary artery disease : one year results of the ESSENCE study Efficacy and safety of Subcataneous Enoxaparin in Non - Q Wave Coronary Events. J Am Coll Cardiol,2000;36:693 - 698. 被引量:1

共引文献5046

同被引文献23

引证文献8

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部